Tolerability of Low‐Dose Oral Minoxidil in Patients With Systemic Lupus Erythematosus: A Retrospective Cohort Study

Ejemplares similares

• Response to “The Role of Patient‐ and Drug‐Related Factors in Oral Minoxidil and Pericardial Effusion: Analyses of Data From the United States Food and Drug Administration Adverse Event Reporting System”
  por: Devyn Zaminski, et al.
  Publicado: (2025)
• Response to Calderon‐Casellas et al., “En Coup D'une Veine: Anatomy of a Novel Morphea Mimicker”
  por: Daniel R. Mazori, et al.
  Publicado: (2025)
• GLP‐1 agonists and hair loss: a call for further investigation
  por: Deesha D. Desai, et al.
  Publicado: (2024)
• Response to “Systemic correlates of cutaneous manifestations of lupus erythematosus”
  por: Carli Needle, et al.
  Publicado: (2024)
• Treatment of Short Anagen Syndrome With Low‐Dose Oral Minoxidil
  por: Nolan Francis, et al.
  Publicado: (2025)